387 related articles for article (PubMed ID: 33680986)
41. Vaginosis: Advances in new therapeutic development and microbiome restoration.
Mohankumar B; Shandil RK; Narayanan S; Krishnan UM
Microb Pathog; 2022 Jul; 168():105606. PubMed ID: 35644292
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of different culture media to support in vitro growth and biofilm formation of bacterial vaginosis-associated anaerobes.
Rosca AS; Castro J; Cerca N
PeerJ; 2020; 8():e9917. PubMed ID: 32974104
[TBL] [Abstract][Full Text] [Related]
43. Comparison of main lactobacillus species between healthy women and women with bacterial vaginosis.
Yan DH; Lü Z; Su JR
Chin Med J (Engl); 2009 Nov; 122(22):2748-51. PubMed ID: 19951608
[TBL] [Abstract][Full Text] [Related]
44.
Panariello BHD; Klein MI; Dias LM; Bellini A; Costa VB; Barbugli PA; Pavarina AC
Biofouling; 2021; 37(9-10):1006-1021. PubMed ID: 34789040
[TBL] [Abstract][Full Text] [Related]
45. Antimicrobial Effects of Sophora flavescens Alkaloids on Metronidazole-Resistant Gardnerella vaginalis in Planktonic and Biofilm Conditions.
Fan L; Liu Z; Zhang Z; Bai H
Curr Microbiol; 2023 Jun; 80(8):263. PubMed ID: 37382659
[TBL] [Abstract][Full Text] [Related]
46. Adhesion of human probiotic Lactobacillus rhamnosus to cervical and vaginal cells and interaction with vaginosis-associated pathogens.
Coudeyras S; Jugie G; Vermerie M; Forestier C
Infect Dis Obstet Gynecol; 2008; 2008():549640. PubMed ID: 19190778
[TBL] [Abstract][Full Text] [Related]
47. Lactobacillus crispatus-loaded electrospun fibers yield viable and metabolically active bacteria that kill Gardnerella in vitro.
Mahmoud MY; Wesley M; Kyser A; Lewis WG; Lewis AL; Steinbach-Rankins JM; Frieboes HB
Eur J Pharm Biopharm; 2023 Jun; 187():68-75. PubMed ID: 37086869
[TBL] [Abstract][Full Text] [Related]
48. Phenotypic surface properties (aggregation, adhesion and biofilm formation) and presence of related genes in beneficial vaginal lactobacilli.
Leccese Terraf MC; Mendoza LM; Juárez Tomás MS; Silva C; Nader-Macías ME
J Appl Microbiol; 2014 Dec; 117(6):1761-72. PubMed ID: 25195810
[TBL] [Abstract][Full Text] [Related]
49. In vitro interactions within a biofilm containing three species found in bacterial vaginosis (BV) support the higher antimicrobial tolerance associated with BV recurrence.
Rosca AS; Castro J; Sousa LGV; França A; Vaneechoutte M; Cerca N
J Antimicrob Chemother; 2022 Jul; 77(8):2183-2190. PubMed ID: 35578895
[TBL] [Abstract][Full Text] [Related]
50. Probiotic
Qian Z; Zhu H; Zhao D; Yang P; Gao F; Lu C; Yin Y; Kan S; Chen D
Microorganisms; 2021 Mar; 9(4):. PubMed ID: 33807455
[No Abstract] [Full Text] [Related]
51.
Johnston W; Ware A; Kuiters WF; Delaney C; Brown JL; Hagen S; Corcoran D; Cummings M; Ramage G; Kean R
Biofilm; 2023 Dec; 5():100101. PubMed ID: 36655001
[TBL] [Abstract][Full Text] [Related]
52. Characterisation and selection of a Lactobacillus species to re-colonise the vagina of women with recurrent bacterial vaginosis.
McLEAN NW; Rosenstein IJ
J Med Microbiol; 2000 Jun; 49(6):543-552. PubMed ID: 10847208
[TBL] [Abstract][Full Text] [Related]
53. Selection of Lactobacillus strains as potential probiotics for vaginitis treatment.
Santos CMA; Pires MCV; Leão TL; Hernández ZP; Rodriguez ML; Martins AKS; Miranda LS; Martins FS; Nicoli JR
Microbiology (Reading); 2016 Jul; 162(7):1195-1207. PubMed ID: 27154285
[TBL] [Abstract][Full Text] [Related]
54. Gardnerella vaginalis outcompetes 29 other bacterial species isolated from patients with bacterial vaginosis, using in an in vitro biofilm formation model.
Alves P; Castro J; Sousa C; Cereija TB; Cerca N
J Infect Dis; 2014 Aug; 210(4):593-6. PubMed ID: 24596283
[TBL] [Abstract][Full Text] [Related]
55. Vaginal & gut microbiota diversity in pregnant women with bacterial vaginosis & effect of oral probiotics: An exploratory study.
Vasundhara D; Raju VN; Hemalatha R; Nagpal R; Kumar M
Indian J Med Res; 2021 Apr; 153(4):492-502. PubMed ID: 34380796
[TBL] [Abstract][Full Text] [Related]
56. The probiotic properties and potential of vaginal Lactobacillus spp. isolated from healthy women against some vaginal pathogens.
Asadi A; Lohrasbi V; Abdi M; Mirkalantari S; Esghaei M; Kashanian M; Oshaghi M; Talebi M
Lett Appl Microbiol; 2022 May; 74(5):752-764. PubMed ID: 35080271
[TBL] [Abstract][Full Text] [Related]
57. Effects of bacterial vaginosis-associated bacteria and sexual intercourse on vaginal colonization with the probiotic Lactobacillus crispatus CTV-05.
Ngugi BM; Hemmerling A; Bukusi EA; Kikuvi G; Gikunju J; Shiboski S; Fredricks DN; Cohen CR
Sex Transm Dis; 2011 Nov; 38(11):1020-7. PubMed ID: 21992977
[TBL] [Abstract][Full Text] [Related]
58. Collagen Peptide in a Combinatorial Treatment with
Jung HY; Cai JN; Yoo SC; Kim SH; Jeon JG; Kim D
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163782
[TBL] [Abstract][Full Text] [Related]
59. Screening of Compounds against Gardnerella vaginalis Biofilms.
Gottschick C; Szafranski SP; Kunze B; Sztajer H; Masur C; Abels C; Wagner-Döbler I
PLoS One; 2016; 11(4):e0154086. PubMed ID: 27111438
[TBL] [Abstract][Full Text] [Related]
60. Lactobacillus casei CRL 431 and Lactobacillus rhamnosus CRL 1224 as biological controls for Aspergillus flavus strains.
Bueno DJ; Silva JO; Oliver G; González SN
J Food Prot; 2006 Oct; 69(10):2544-8. PubMed ID: 17066943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
